Mar 18
|
A Biobank for the Americas and a Genomics Lab Power Precision Health for All
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
Mar 13
|
10 Biggest Stocks Targeted By Activist Investors Right Now
|
Mar 12
|
Carl Icahn Drops Plans for New Proxy Fight at Illumina
|
Mar 12
|
Exclusive-Icahn drops Illumina board challenge threat, sources say
|
Mar 8
|
Finding the Needle in the Genomic Haystack With DRAGEN
|
Mar 7
|
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
|
Mar 7
|
Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World
|
Jan 19
|
Here’s Why Polen Focus Growth Sold Illumina (ILMN)
|
Jan 19
|
Illumina, Inc. (NASDAQ:ILMN) is largely controlled by institutional shareholders who own 90% of the company
|
Jan 18
|
Here’s How the New AI Algorithm Helps Illumina (ILMN)
|
Jan 16
|
Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results
|
Jan 15
|
Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world
|
Jan 12
|
What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage
|
Jan 11
|
What Happens When a Virus Becomes a Permanent Part of Your Genome?
|
Jan 9
|
Match Group, Juniper- HPE talks, Illumina: Trending Tickers
|
Jan 9
|
Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
|
Jan 9
|
Why Illumina Rallied 36.6% in December
|
Jan 9
|
Illumina unveils preliminary fourth-quarter revenue that tops estimates
|
Jan 9
|
Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi
|